Our results indicated that the CD4+ CTL subset expressed PRF1, GZMA, and GZMB, indicating that CD4+ CTLs may induce apoptosis in tumor cells via the release of cytotoxic mediators, especially granzyme B and perforin. Here, CD4 is linked to neoplasm.